Rx May Offer Hope for Some Non-Hodgkin Lymphoma Patients
Most patients with a slow-growing form of non-Hodgkin lymphoma respond well to therapy at first. But the disease can return and become resistant to therapy. A new medication may change this pattern.
It Took Two to Fight Lymphoma
Treatment for follicular lymphoma — the most common type of non-Hodgkin lymphoma — often comes with serious side effects. New research may change that for many patients.
Closing In on a Cure
Someone diagnosed with any type of leukemia in the early 1960s had about a 14 percent chance of being alive five years later. Today, those chances are vastly greater.